Meridian Wealth Management, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1697300
LEXINGTON, KY
Position in LGND
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$253,188
-$432,452 QoQ
Shares Held
801
-91.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#291
of 411 holders
Holding Since
Jun 2020
2 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meridian Wealth Management, LLC holds $7,258,442 across 7 Biotechnology names. LGND ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
22,028 | $5,391,793 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
132,256 | $751,214 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
742 | $368,573 | |
| 4 | DMAC |
DiaMedica Therapeutics Inc.
|
43,600 | $306,944 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
This page
|
801 | $253,188 | |
| 6 | NMRA |
Neumora Therapeutics, Inc.
|
94,400 | $160,480 | |
| 7 | BYSI |
BeyondSpring Inc.
|
15,000 | $26,250 |
All Filings in LGND
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $253,188 | 801 | Shares | Sole | 2026-08-05 | |
| 2020-06-30 | $685,640 | 6,130 | Shares | Sole | 2020-07-15 | |
| No filing history on record for this holder in this stock. | ||||||